| Literature DB >> 26506837 |
Yeomoon Sim1, Hyein Oh2, Dal-Seok Oh3, Namkwon Kim4, Pil Sung Gu5, Jin Gyu Choi6, Hyo Geun Kim7, Tong Ho Kang8, Myung Sook Oh9,10.
Abstract
BACKGROUND: Rhei Rhizoma (RR) has been widely used as laxative and processed to alter its therapeutic actions or reduce its side effects. In this study, we evaluated experimentally the clinical application guideline that RR should be alcohol-steamed seven times before being used in elderly patients, as described in Dongeuibogam, the most famous book on Korean traditional medicine.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26506837 PMCID: PMC4624659 DOI: 10.1186/s12906-015-0922-y
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Fig. 1Sennoside A, sennoside B and emodin constituent changes in unprocessed or processed Rhei Rhizoma
Fig. 2Effects of unprocessed or processed Rhei Rhizoma on HepG2 cell viability. Cells were treated with RR-U, RR-P1, RR-P4 and RR-P7 at concentration of 100 μg/mL for 4 h. Cell viability was presented as a percentage of the control. ** p < 0.01 and *** p < 0.001 compared with the control group. ### p < 0.001 compared with RR-U or RR-P1 treated group
Effect of unprocessed or processed Rhei Rhizoma on rat body and liver weights
| Control | RR-U | RR-P1 | RR-P4 | RR-P7 | |
|---|---|---|---|---|---|
| Body weight (g) | 339.53 ± 6.54 | 290.48 ± 7.97*** | 326.83 ± 9.23### | 333.77 ± 12.42### | 339.18 ± 10.10### |
| Liver weight (g) | 14.21 ± 0.58 | 14.17 ± 0.71 | 13.12 ± 1.07 | 13.03 ± 0.78 | 15.07 ± 0.92 |
| Relative weight (%) | 4.19 ± 0.25 | 4.88 ± 0.21* | 4.01 ± 0.27## | 3.90 ± 0.24## | 4.44 ± 0.26 |
Relative weight: liver weight/body weight × 100. * p < 0.05 and *** p < 0.001 compared with the control group
## p < 0.01 and ### p < 0.001 compared with RR-U treated group
Effect of unprocessed or processed Rhei Rhizoma on biochemical indices of rats
| Control | RR-U | RR-P1 | RR-P4 | RR-P7 | |
|---|---|---|---|---|---|
| T-BIL (mg/dL) | 0.05 ± 0.01 | 0.30 ± 0.07*** | 0.11 ± 0.01## | 0.09 ± 0.01### | 0.09 ± 0.01## |
| AST (IU/L) | 94.15 ± 2.63 | 100.33 ± 6.44 | 86.52 ± 7.59 | 88.44 ± 6.72 | 81.92 ± 1.64# |
| ALT (IU/L) | 44.38 ± 1.68 | 48.95 ± 2.01* | 46.60 ± 4.37 | 42.62 ± 4.26**### | 38.45 ± 1.28*## |
| ALP (IU/L) | 301.18 ± 22.60 | 300.17 ± 31.66 | 257.45 ± 28.04 | 283.70 ± 25.88 | 293.73 ± 40.03 |
| γ-GT (IU/L) | 0.02 ± 0.02 | 0.14 ± 0.07 | 0.02 ± 0.02 | 0.02 ± 0.02 | 0.09 ± 0.05 |
* p < 0.05, ** p < 0.01, and *** p < 0.001 compared with the control group. # p < 0.05, ## p < 0.01, and ### p < 0.001 compared with RR-U treated group
Fig. 3Liver morphologies of unprocessed or processed Rhei Rhizoma. Typical histopathological features of the rats treated with RR-U, RR-P1, RR-P4 and RR-P7. The yellowish brown bile pigments (white dashed circles). Scale bar = 50 μm